All Publications:

This page links to some files in Portable Document Format (PDF).


SRAB Publications (Sorted by Author)

B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Bastian LA, Breslau ES, Davis WW, Moser RP. Hormone Therapy for Menopausal Symptoms: Tracking the Translation of Women's Health Initiative findings into practice. Journal of Clinical Outcomes Management 2005;12(3):140-146.

Bell BS. Spatial Analysis of Disease - Applications. In: Beam C, ed. Biostatistical Applications in Cancer Research. Boston: Kluwer Academic Publishers; Jan 2002. p. 151-182. [View PDF]

Bell BS, Hoskins RE, Pickle LW, Wartenberg D. Current practices in spatial analysis of cancer data: mapping health statistics to inform policymakers and the public. Int J Health Geogr 2006;5:49.

Berrigan D, Dodd K, Troiano RP, Krebs-Smith SM, Barbash RB. Patterns of health behavior in U.S. adults. Prev Med May 2003;36(5):615-23.

Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 27 Oct 2005;353(17):1784-92.

Black MM, Zachrau RE, Hankey BF, Feuer EJ. Prognostic significance of in situ carcinoma associated with invasive breast carcinoma. A natural experiment in cancer immunology? Cancer 15 Aug 1996;78(4):778-88.

Boer R, Ries LA, van Ballegooijen M, Feuer EJ, Legler JM, Habbema JD. Ambiguities In Calculating Cancer Patient Survival: The SEER Experience for Colorectal and Prostate Cancer. Statistical Research and Applications Branch, National Cancer Institute: 2003. Technical Report # 2003-05. Available at http://srab.cancer.gov/reports/.

Boscoe FP, Pickle LW. Choosing geographic units for choropleth rate maps, with an emphasis on public health applications. Cartography and GIS 2003;30(3):237-248.

Breen N, A Cronin K, Meissner HI, Taplin SH, Tangka FK, Tiro JA, McNeel TS. Reported drop in mammography : is this cause for concern? Cancer 15 Jun 2007;109(12):2405-9.

Breen N, Feuer EJ, Depuy S, Zapka J. The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium. Public Health Rep Sep 1997;112(5):423-32.

Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 21 Nov 2001;93(22):1704-13.

Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study. Ethn Dis 1999;9(1):111-25.

Breslau ES, Davis WW, Doner L, Eisner EJ, Goodman NR, Meissner HI, Rimer BK, Rossouw JE. The hormone therapy dilemma: women respond. J Am Med Womens Assoc 2003;58(1):33-43.

Brewer CA, MacEachren AM, Pickle LW. Choice of colors for the new NCHS mortality atlas. Proceedings of International Symposium on Computer Mapping in Epidemiology and Environmental Health; 14 Feb 1995; Tampa, FL. 1997. p. 14-20.

Brewer CA, MacEachren AM, Pickle LW, Herrmann DJ. Mapping mortality: Evaluating color schemes for choropleth maps. Annals of the Amer Assoc of Geographers Sep 1997;87(3):411-438.

Brewer CA, Pickle LW. Evaluation of methods for classifying epidemiological data on choropleth maps in series. Annals of the Amer Assoc of Geographers Dec 2002;92(4):662-681.

Brown CC, Kessler LG. Projections of lung cancer mortality in the United States: 1985-2025. J Natl Cancer Inst 2 Mar 1988;80(1):43-51.

Bunin GR, Feuer EJ, Witman PA, Meadows AT. Increasing incidence of childhood cancer: report of 20 years experience from the greater Delaware Valley Pediatric Tumor Registry. Paediatr Perinat Epidemiol Jul 1996;10(3):319-38.

Byrne J, Kessler LG, Devesa SS. The prevalence of cancer among adults in the United States: 1987. Cancer 15 Apr 1992;69(8):2154-9.

Campbell MK, Feuer EJ, Wun LM. Cohort-specific risks of developing breast cancer to age 85 in Connecticut. Epidemiology May 1994;5(3):290-6.

Carr DB, Bell BS, Pickle LW, Zhang Y, Li Y. The state cancer profiles web site and extensions of linked micromap plots and conditioned choropleth map plots. Proceedings of 2003 National Conference on Digital Government Research; 2003; Boston, MA. ACM International Conference Proceeding Series; Vol. 130: 2003. p. 1-5.

Carr DB, Chen JX, Bell BS, Pickle LW, Zhang Y. Interactive linked micromap plots and dynamically conditioned choropleth maps. Proceedings of 2002 National Conference on Digital Government Research; Los Angeles, California. CM International Conference Proceeding Series; Vol. 129; 2002. p. 61-68.

Carr DB, Pickle LW. Topics in scientific visualization: Plot production issues and details. Statistical Computing and Statistical Graphics Newsletter 1993;4(2):16-20.

Centers for Disease Control and Prevention (CDC). Cancer survivorship--United States, 1971-2001. MMWR. Morbidity and mortality weekly report 25 Jun 2004;53(24):526-9.

Chu KC, Miller BA, Feuer EJ, Hankey BF. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol Dec 1994;47(12):1451-61.

Clarke LD, Plevritis SK, Boer R, Cronin KA, Feuer EJ. A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. J Natl Cancer Inst Monogr 2006;(36):96-105.

Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 16 Oct 2002;94(20):1537-45.

Clegg LX, Gail MH, Feuer EJ. Estimating the variance of disease-prevalence estimates from population-based registries. Biometrics Sep 2002;58(3):684-8.

Coleman EA, Feuer EJ. Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium. Ann Intern Med 1 Dec 1992;117(11):961-6.

Coleman EA, Kessler LG, Wun LM, Feuer EJ. Trends in the surgical treatment of ductal carcinoma in situ of the breast. Am J Surg Jul 1992;164(1):74-6.

Coughlin SS, Nass CC, Pickle LW, Trock B, Bunin G. Regression methods for estimating attributable risk in population-based case-control studies: a comparison of additive and multiplicative models. Am J Epidemiol 1 Feb 1991;133(3):305-13.

Coughlin SS, Pickle LW. Sensitivity and specificity-like measures of the validity of a diagnostic test that are corrected for chance agreement. Epidemiology Mar 1992;3(2):178-81.

Coughlin SS, Pickle LW, Goodman MT, Wilkens LR. The logistic modeling of interobserver agreement. J Clin Epidemiol Nov 1992;45(11):1237-41.

Coughlin SS, Trock B, Criqui MH, Pickle LW, Browner D, Tefft MC. The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. J Clin Epidemiol Jan 1992;45(1):1-7.

Croner CM, Pickle LW, Wolf DR, White AA. A GIS approach to hypothesis generation in epidemiology. Proceedings of American Congress on Surveys and Mapping; 1992. p. 275-283.

Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med 15 Jul 2000;19(13):1729-40.

Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr 2006;(36):112-21.

Cronin KA, Feuer EJ, Wesley MN, Mariotto AB, Scoppa S, Green DT. Current Estimates for 5 and 10 Year Relative Survival. Statistical Research and Applications Branch, National Cancer Institute; 2003. Technical Report # 2003-04. Available at http://srab.cancer.gov/reports/.

Cronin KA, Freedman LS, Lieberman R. Reply to the Dissent by Hans C. van Houwelingen. J Clin Epidemiol 1999;52(8):715-716.

Cronin KA, Freedman LS, Lieberman R, Weiss HL, Beenken SW, Kelloff GJ. Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol Aug 1999;52(8):705-11.

Cronin KA, Gail MH, Zou Z, Bach PB, Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst 3 May 2006;98(9):637-40.

Cronin KA, Krebs-Smith SM, Feuer EJ, Troiano RP, Ballard-Barbash R. Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States). Cancer Causes Control May 2001;12(4):305-16.

Cronin KA, Legler JM, Etzioni RD. Assessing uncertainty in microsimulation modelling with application to cancer screening interventions. Stat Med 15 Nov 1998;17(21):2509-23.

Cronin KA, Mariotto AB, Clarke LD, Feuer EJ. Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality. J Natl Cancer Inst Monogr 2006;(36):26-9.

Cronin KA, Mariotto AB, Scoppa S, Green DT, Clegg LX. Differences Between Brenner et al. and NCI Methods for Calculating Period Survival. Statistical Research and Applications Branch, National Cancer Institute; 2003. Technical Report # 2003-02. Available at http://srab.cancer.gov/reports/.

Cronin KA, Weed DL, Connor RJ, Prorok PC. Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 1 Apr 1998;90(7):498-504.

Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ. Modeling the dissemination of mammography in the United States. Cancer Causes Control Aug 2005;16(6):701-12.

Cubbin C, Pickle LW, Fingerhut L. Social context and geographic patterns of homicide among US black and white males. Am J Public Health Apr 2000;90(4):579-87.

Das B, Clegg L, Feuer EJ, Pickle LW. A New Method to Evaluate the Completeness of Case Ascertainment by a Cancer Registry. Cancer Causes and Control In Press.

Das B, Feuer EJ, Mariotto A. Geographic association between mammography use and mortality reduction in the US. Cancer Causes Control Aug 2005;16(6):691-9.

Davis WW, Flegal KM. Comparing the Areas under Receiver Operating Characteristic Curves for Cluster Designs. Proceedings of Survey Research Section of the American Statistical Association; Aug 2003; San Francisco, California. 2003. p. 1182-1189.

Davis WW, Graubard BI, Hartman AM, Stillman FA. Descriptive methods for evaluation of state-based intervention programs. Eval Rev Oct 2003;27(5):506-34.

Davis WW, Hartman AM, Gibson JT. Bridging Estimates by Race for the Tobacco Use Supplement to the Current Population Survey – (TUS-CPS). May 2006. Available at http://riskfactor.cancer.gov/studies/tus-cps/race_bridging_071307.pdf.

Davis WW, Hartman AM, Gibson JT. Weighting the overlap sample obtained from two tobacco supplements to the Current Population Survey. Oct 2007. Available at http://riskfactor.cancer.gov/studies/tus-cps/TUS-CPS_overlap.pdf.

Davis WW, McNeel T, Lee S, Brick M, Nguyen HA, Flores-Cervantes I. Examining trends and averages using combined cross-sectional survey data from multiple years. CHIS 2005 Methodology Paper. Oct 2006. Available at http://www.chis.ucla.edu/pdf/chis_pooling_10302006.pdf.

Davis WW, Soman C, Zou J. Small area prevalence estimates using two surveys . Proceedings of American Statistical Association Survey Research Methods Section; 2007. p. 2923-30.

Decouflé P, Thomas TL, Pickle LW. Comparison of the proportionate mortality ratio and standardized mortality ratio risk measures. Am J Epidemiol Mar 1980;111(3):263-9.

Department of Health and Human Services. Comments of the Department of Health and Human Services on the General Accounting Office`s Draft Report on Breast Cancer: Patients have yet to realize the benefits of adjuvant chemotherapy. In: Breast Cancer Patients` Survival. Washington D.C.: U.S. General Accounting Office; Feb 1989. p. 34-51.

Dodd KW, Guenther PM, Freedman LS, Subar AF, Kipnis V, Midthune D, Tooze JA, Krebs-Smith SM. Statistical methods for estimating usual intake of nutrients and foods: a review of the theory. J Am Diet Assoc Oct 2006;106(10):1640-50.

Duczmal L, Kulldorff M, Huang L. Evaluation of spatial scan statistics for irregular shaped clusters. Journal of Computational and Graphical Statistics Jun 2006;15(2):428-42.

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 5 Oct 2005;97(19):1407-27.

Edwards MJ, Gamel JW, Feuer EJ. Improvement in the prognosis of breast cancer from 1965 to 1984. J Clin Oncol Mar 1998;16(3):1030-5.

Elliott M, Davis WW. Obtaining Cancer Risk Factor Prevalence Estimates in Small Areas: Combining data from two surveys. Applied Statistics: Journal of the Royal Statistical Society -Series C Jun 2005;54:595-609.

Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. Urology Feb 2002;59(2):251-5.

Etzioni R, Cha R, Feuer EJ, Davidov O. Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol 15 Oct 1998;148(8):775-85.

Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 16 Jun 1999;91(12):1033-9.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 3 Jul 2002;94(13):981-90.

Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, Ditommaso D, Karnaofski K, Gulati R, Penson DF, Feuer EJ. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control Mar 2008;19(2):175-81.

Etzioni RD, Feuer EJ, Sullivan SD, Lin D, Hu C, Ramsey SD. On the use of survival analysis techniques to estimate medical care costs. J Health Econ Jun 1999;18(3):365-80.

Faden VB, Fay MP. Trends in drinking among Americans age 18 and younger: 1975-2002. Alcohol Clin Exp Res Sep 2004;28(9):1388-95.

Fay MP. Approximate confidence intervals for rate ratios from directly standardized rates with sparse data. Communications in Statistics:Theory and Methods 1999;28:2141-60.

Fay MP. Comparing several score tests for interval censored data. Stat Med 15 Feb 1999;18(3):273-85.

Fay MP. Estimating age conditional probability of developing disease from surveillance data. Popul Health Metr 27 Jul 2004;2(1):6.

Fay MP. Estimating age-conditional probablity of developing cancer using a piecewise mid-age joinpoint model for the rates. Statistical Research and Applications Branch, National Cancer Institute; 2003. Technical Report # 2003-03. Available at http://srab.cancer.gov/reports/.

Fay MP. Measuring a Binary Response's Range of Influence in Logistic Regression. The American Statistician 1 Feb 2002;56:5-9.

Fay MP. Rank invariant tests for interval censored data under the grouped continuous model. Biometrics Sep 1996;52(3):811-22.

Fay MP, Feuer EJ. A semi-parametric estimate of extra-Poisson variation for vital rates. Stat Med 15 Nov 1997;16(21):2389-401.

Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 15 Apr 1997;16(7):791-801.

Fay MP, Follmann DS. Designing Monte Carlo implementations of permutation or bootstrap hypothesis tests. American Statistician 1 Feb 2002;56:63-70.

Fay MP, Freedman LS. Meta-analyses of dietary fats and mammary neoplasms in rodent experiments. Breast Cancer Res Treat Nov 1997;46(2-3):215-23.

Fay MP, Freedman LS, Clifford CK, Midthune DN. Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res 15 Sep 1997;57(18):3979-88.

Fay MP, Gennings C. Non-parametric two-sample tests for repeated ordinal responses. Stat Med 28 Feb 1996;15(4):429-42.

Fay MP, Graubard BI. Small-sample adjustments for Wald-type tests using sandwich estimators. Biometrics Dec 2001;57(4):1198-206.

Fay MP, Graubard BI, Freedman LS, Midthune DN. Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics Mar 1998;54(1):195-208.

Fay MP, Lee J. Measuring agreement between two statistics with applications to age-standardization. Journal of the Royal Statistical Society 2006;169 part 1:81-96.

Fay MP, Midthune DN, Graubard B, Freedman LS. Meta analyses using conditional logistic regression with sandwich estimators. Proceedings of Biopharmaceutical Section, American Statistical Association; 1999.

Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ. Age-conditional probabilities of developing cancer. Stat Med 15 Jun 2003;22(11):1837-48.

Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ. Comparison of Two Methods for Calculating Age-Conditional Probabilities of Developing Cancer. Statistical Research and Applications Branch, National Cancer Institute; 2002. Technical Report #2002-01. Available at http://srab.cancer.gov/reports/.

Fay MP, Shih JH. Permutation tests using estimated distribution functions. J Am Stat Assoc 1993;93:387-396.

Fay MP, Tiwari RC, Feuer EJ, Zou Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics Sep 2006;62(3):847-54.

Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. N Engl J Med 27 Nov 1986;315(22):1394-7.

Ferris DG, Cox TJ, Burke L, Litaker MS, Harper DM, Campion MJ, Greenberg MD, McShane L, Wun L. Colposcopy quality control: Establishing colposcopy criteron standards for the NCI ALTS trial. Journal of Lower Genital Tract Disease 1998;2:195-203.

Feuer EJ. Incidence of testicular cancer in U.S. men (Stat bite). J Natl Cancer Inst 1995;87(6):405.

Feuer EJ. Lifetime probability of Cancer (Stat bite). J Natl Cancer Inst 1996;89:279.

Feuer EJ. Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem. J Natl Cancer Inst Monogr 2006;(36):2-6.

Feuer EJ, Boer R, Holford TR. Developing and comparing population models for the early detection of cancer. Statistical Methods in Medical Research 2004;13:419-420.

Feuer EJ, Etzioni R, Cronin KA, Mariotto A. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res Dec 2004;13(6):421-42.

Feuer EJ, Frey CM, Brawley OW, Nayfield SG, Cunningham JB, Geller NL, Bosl GJ, Kramer BS. After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer. J Clin Oncol Feb 1994;12(2):368-77.

Feuer EJ, Hankey BF, Gaynor JJ, Wesley MN, Baker SG, Meyer JS. Graphical representation of survival curves associated with a binary non-reversible time dependent covariate. Stat Med 28 Feb 1992;11(4):455-74.

Feuer EJ, Kessler LG. Test statistic and sample size for a two-sample McNemar test. Biometrics Jun 1989;45(2):629-36.

Feuer EJ, Kessler LG, Baker SG, Triolo HE, Green DT. The impact of breakthrough clinical trials on survival in population based tumor registries. J Clin Epidemiol 1991;44(2):141-53.

Feuer EJ, Mariotto A, Merrill R. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates. Cancer 15 Aug 2002;95(4):870-80.

Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 16 Jun 1999;91(12):1025-32.

Feuer EJ, Miller BA. Stat Bite: Breast and Lung/Bronchus Cancers in U.S. Women by Geographic Area. J Natl Cancer Inst 1991;83(20):1437.

Feuer EJ, Sheinfeld J, Bosl GJ. Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. J Natl Cancer Inst 19 May 1999;91(10):816-8.

Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 15 Dec 1992;136(12):1423-36.

Feuer EJ, Wun LM, Boring CC. Probability of developing cancer. In: Miller BA, Ries LA, Hankey BF, Kosary CL, Edwards BK, eds. Cancer Statistics Review: 1973-1989. National Cancer Institute, NIH pub.No.92-2789; 1992.

Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst 2 Jun 1993;85(11):892-7.

Freedman AN, Wideroff L, Olson L, Davis W, Klabunde C, Srinath KP, Reeve BB, Croyle RT, Ballard-Barbash R. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A 1 Jul 2003;120(1):63-71.

Freedman LS, Midthune D, Carroll RJ, Krebs-Smith S, Subar AF, Troiano RP, Dodd K, Schatzkin A, Bingham SA, Ferrari P, Kipnis V. Adjustments to improve the estimation of usual dietary intake distributions in the population. J Nutr Jul 2004;134(7):1836-43.

Frey CM, Feuer EJ, Timmel MJ. Projection of incidence rates to a larger population using ecologic variables. Stat Med 15 Sep 1994;13(17):1755-70.

Frey CM, Hartman AM. Stat Bite: U.S. Trends in Melanoma Incidence and Mortality. J Natl Cancer Inst 1991;83(23):1705.

Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates. J Natl Cancer Inst 3 Jun 1992;84(11):872-7.

Gamel JW, Meyer JS, Feuer E, Miller BA. The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma. Cancer 15 Apr 1996;77(8):1459-64.

Gamel JW, Weller EA, Wesley MN, Feuer EJ. Parametric cure models of relative and cause-specific survival for grouped survival times. Comput Methods Programs Biomed Feb 2000;61(2):99-110.

Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, Clarkson BD, Brennan MF. On the use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology . J Am Stat Assoc Jun 1993;88:400-409.

Ghosh K, Tiwari RC. Empirical Process Approach to Some Two-Sample Problems Based on Ranked Set Samples. Annals of Institute of Statistical Mathematics In Press.

Ghosh K, Tiwari RC. Estimating the Distribution Function Using k-tuple Ranked Set Samples. Journal of Statistical Planning and Inference In Press.

Ghosh K, Tiwari RC. Nonparametric and Semiparametric Bayes Reliability Analysis. Encyclopedia of Statistics in Quality and Reliability In Press.

Ghosh K, Tiwari RC, Feuer EJ, Cronin KA, Jemal A. Predicting US Cancer Mortality Counts Using State Space Models. In: Khattree R, Naik DN, eds. Computational Methods in Biomedical Researh. Boca Ratan, FL: Chaptman and Hall/CRC; 2008. p. 131-151.

Gigli A, Mariotto A, Clegg LX, Tavilla A, Corazziari I, Capocaccia R, Hachey M, Steve S. Estimating the variance of cancer prevalence from population-based registries. Stat Methods Med Res Jun 2006;15(3):235-53.

Gregorio DI, Huang L, DeChello LM, Samociuk H, Kulldorff M. Place of residence effect on likelihood of surviving prostate cancer. Ann Epidemiol Jul 2007;17(7):520-4.

Gumpertz ML, Pickle LW, Miller BA, Bell BS. Geographic patterns of advanced breast cancer in Los Angeles: associations with biological and sociodemographic factors (United States). Cancer Causes Control Apr 2006;17(3):325-39.

Habbema JD, Schechter CB, Cronin KA, Clarke LD, Feuer EJ. Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst Monogr 2006;(36):122-6.

Habbema JD, Tan SY, Cronin KA. Impact of mammography on U.S. breast cancer mortality, 1975-2000: are intermediate outcome measures informative? J Natl Cancer Inst Monogr 2006;(36):105-11.

Hall NG, Hershey JC, Kessler LG, Stotts RC. A model for making project funding decisions at the National Cancer Institute. Oper Res Nov 1992;40(6):1040-52.

Han PK, Kobrin SC, Klein WM, Davis WW, Stefanek M, Taplin SH. Perceived ambiguity about screening mammography recommendations: association with future mammography uptake and perceptions. Cancer Epidemiol Biomarkers Prev Mar 2007;16(3):458-66.

Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 16 Jun 1999;91(12):1017-24.

Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Causes Control Jan 2000;11(1):31-5.

Hao Y, Ward EM, Jemal A, Pickle LW, Thun MJ. U.S. congressional district cancer death rates. Int J Health Geogr 2006;5:28.

Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman ME. An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by socioeconomic position and race-ethnicty, 1992. Am J Epidemiol In Press.

Herrmann DJ, Kerwin J, Pickle LW, Croner CM, White AA, Jobe JB, Jones GK. Cognitive processes in statistical map reading. Proceedings of Statistical Graphics Section, American Statistical Association Meeting; 1993; San Francisco, CA. 1994. p. 51-54.

Herrmann DJ, Pickle LW. A cognitive subtask model of statistical map reading. NCHS Working Paper Series Report, No. 18. 1994. No.11.

Herrmann DJ, Pickle LW. A cognitive subtask model of statistical map reading. Visual Cognition 1 Jun 1996;3:165-190.

Herrmann DJ, Pickle LW. The new cognitive perspective in statistical map reading. Proceedings of Statistical Graphics Section, American Statistical Association Meeting; 1995; Orlando, FL. 1996. p. 4-7.

Holford TR, Cronin KA, Mariotto AB, Feuer EJ. Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr 2006;(36):19-25.

Huang L, Chen M, Anderson G. Bayesian analysis of the mixed models for repeated binary response and time-dependent missing covariates. Journal of Agricultural, Biological, and Environmental Statistics In Press.

Huang L, Chen MH, Ibrahim JG. Bayesian analysis for generalized linear models with nonignorably missing covariates. Biometrics Sep 2005;61(3):767-80.

Huang L, Cronin KA, Mariotto A, Johnson K, Feuer EJ. Improved survival time: What can survival cure models tell us about population-based survival improvement in late stage colorectal, ovarian, and testicular cancer? Cancer In Press.

Huang L, Kulldorff M, Gregorio D. A spatial scan statistic for survival data. Biometrics Mar 2007;63(1):109-18.

Huang L, Pickle LW, Stinchcomb D, Feuer EJ. Detection of spatial clusters: application to cancer survival as a continuous outcome. Epidemiology Jan 2007;18(1):73-87.

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55(1):10-30.

Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin Jan 2004;54(1):8-29.

Johnson KA, Pickle LW. Risk of breast cancer in the Nurses' Health Study: applying the Gail model. JAMA 1993;270(24):2925-6.

Jones GK, Pickle LW, Mungiole M. The use of the SAS programming language and procedures to model and process data used in creating the new U.S. Mortality Atlas. Proceedings of 21st Annual SAS Users' Group International Conference; 1996. p. 1074-1079.

Kessler L, Fintor L, Muha C, Wun LM, Annett D, Mazan KD. The Cancer Information Service Telephone Evaluation and Reporting System (CISTERS): a new tool for assessing quality assurance. J Natl Cancer Inst Monogr 1993;(14):61-5.

Kessler LG, Feuer EJ, Brown ML. Projections of the breast cancer burden to U.S. women: 1990-2000. Prev Med Jan 1991;20(1):170-82.

Kim H, Yu B, Feuer EJ. Infernence in segmented line regression: A simulation study. Journal of Statistical Computation and Simulation In Press.

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 15 Feb 2000;19(3):335-51.

Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics Dec 2004;60(4):1005-14.

Klabunde CN, Jones E, Brown ML, Davis WW. Colorectal cancer screening with double-contrast barium enema: a national survey of diagnostic radiologists. AJR. American journal of roentgenology Dec 2002;179(6):1419-27.

Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol Dec 2000;53(12):1258-67.

Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL. Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study. Med Care Apr 2005;43(4):391-400.

Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med Apr 2006;30(4):313-9.

Knopf KB, Warren JL, Feuer EJ, Brown ML. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc Nov 2001;54(5):563-71.

Kulldorff M, Athas WF, Feuer EJ, Miller BA, Key CR. Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico. Am J Public Health Sep 1998;88(9):1377-80.

Kulldorff M, Feuer EJ, Miller BA, Freedman LS. Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol 15 Jul 1997;146(2):161-70.

Kulldorff M, Huang L, Pickle L, Duczmal L. An elliptic spatial scan statistic. Stat Med 30 Nov 2006;25(22):3929-43.

Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev Jan 2002;11(1):59-71.

Legler J, Potosky AL, Gilliland FD, Eley JW, Stanford JL. Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study. Med Care Aug 2000;38(8):847-57.

Legler JM, Davis WW, Potosky AL, Hoffman RM. Latent variable modelling of recovery trajectories: sexual function following radical prostatectomy. Stat Med 30 Sep 2004;23(18):2875-93.

Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control Oct 1998;9(5):519-27.

Legler JM, Gloeckler Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality. J Natl Cancer Inst 1 Dec 1999;91(23):2050A-22051.

Legler JM, Gloeckler Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. RESPONSE: re: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 5 Jan 2000;92(1):77A-8.

Legler JM, Lefkopoulou M, Ryan LM. Efficiency and power of tests for multiple binary outcomes. J Am Stat Assoc Jun 1995;90(430):680-693.

Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 18 Aug 1999;91(16):1382-90.

Levin DL, Gail MH, Kessler LG, Eddy DM. A model for projecting cancer incidence and mortality in the presence of prevention screening, and treatment programs. Cancer control objectives for the nation: 1985-2000. NCI Monographs Number 2. 1986. NIH Pub. No.86-2880.

Lewandowsky S, Herrmann DJ, Behrens JT, Li S, Pickle LW, Jobe JB. Perception of clusters in statistical maps. Appl Cog Psych 19 Mar 1993;7:533-551.

Li Y, Tiwari RC. Comparing trends in cancer rates across overlapping regions. Biometrics 2008. In Press.

Li Y, Tiwari RC, Guha S. Mixture Cure Survival Models with Dependent Censoring. Journal of the Royal Statistical Society, Series B (Statistical Methodology) Jun 2007;69(3):285-306.

Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data. Biometrics Jun 1997;53(2):419-34.

MacEachren AM, Boscoe F, Huag D, Pickle LW. Geographic visualization: Designing manipulable maps for exploring temporally varying georeferenced statistics. Proceedings of IEEE Symposium on Information Visualization; Research Triangle Park, NC. 1998. p. 87-94.

MacEachren AM, Brewer CA, Pickle LW. Mapping health statistics: Representing data reliability. Proceedings of 17th International Cartographic Association Conference; 11 Sep 1995; Barcelona, Spain. 1995. p. 311-31.

MacEachren AM, Brewer CA, Pickle LW. Visualizing georeferenced data: Representing reliability in health statistics. Environment and Planning 1998;30:1547-1561.

MacEachren AM, Hardisty F, Dai X, Pickle LW. Supporting visual analysis of federal geospatial statistics. Commun ACM Jan 2003;46(1):63-64.

MacEachren AM, Polsky C, Haug D, Brown D, Boscoe F, Beedasy J, Pickle LW, Marrara M. Visualizing spatial relationships among health, environmental, and demographic statistics: Interface design issues. Proceedings of 18th International Cartographic Conference; 1997; Stockholm, Sweden. 1998. p. 880-887.

Manley MW, Pierce JP, Gilpin EA, Rosbrook B, Berry C, Wun LM. Impact of the American Stop Smoking Intervention Study on cigarette consumption. Tob Control 1997;6 Suppl 2:S12-6.

Mariotto A, Capocaccia R, Verdecchia A, Micheli A, Feuer EJ, Pickle L, Clegg LX. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control Mar 2002;13(2):101-11.

Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 6 Nov 2002;94(21):1626-34.

Mariotto A, Gigli A, Capocaccia R, Clegg L, Scoppa S, Ries LA, Tesauro GS, Rowland JS, Feuer EJ. Complete and Limited Duration Prevalence Estimates. In: SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute; 2002.

Mariotto A, Warren JL, Knopf KB, Feuer EJ. The prevalence of patients with colorectal carcinoma under care in the U.S. Cancer 15 Sep 2003;98(6):1253-61.

Mariotto AB, Etzioni R, Krapcho M, Feuer EJ. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey. Cancer 1 May 2007;109(9):1877-86.

Mariotto AB, Feuer EJ, Harlan LC, Abrams J. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr 2006;(36):7-15.

Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev Mar 2007;16(3):566-71.

Mariotto AB, Wesley MN, Cronin KA, Johnson KA, Feuer EJ. Estimates of long-term survival for newly diagnosed cancer patients: a projection approach. Cancer 1 May 2006;106(9):2039-50.

Mariotto AB, Yabroff KR, Feuer EJ, De Angelis R, Brown M. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control Dec 2006;17(10):1215-26.

Meissner HI, Breen N, Coyne C, Legler JM, Green DT, Edwards BK. Breast and cervical cancer screening interventions: an assessment of the literature. Cancer Epidemiol Biomarkers Prev Oct 1998;7(10):951-61.

Meissner HI, Rimer BK, Davis WW, Eisner EJ, Siegler IC. Another round in the mammography controversy. J Womens Health (Larchmt) Apr 2003;12(3):261-76.

Merrill RM. Changes in the use of radical prostatectomy for treating prostate cancer in the USA. Lancet 5 Oct 1996;348(9032):963-4.

Merrill RM. Stat Bite: Trends in Corpus Uteri Cancer Incidence . J Natl Cancer Inst 1996;88:1019.

Merrill RM. Trends in prostate cancer incidence and surgery (Stat Bite). J Natl Cancer Inst Apr 1996;88:403.

Merrill RM. Stat Bite: Trends in prostate cancer incidence. J Natl Cancer Inst 22 Nov 1996;88(22):1617.

Merrill RM, Brawley OW. Prostate cancer incidence and mortality rates among white and black men. Epidemiology Mar 1997;8(2):126-31.

Merrill RM, Brown ML, Potosky AL, Riley G, Taplin SH, Barlow W, Fireman BH. Survival and treatment for colorectal cancer Medicare patients in two group/staff health maintenance organizations and the fee-for-service setting. Med Care Res Rev Jun 1999;56(2):177-96.

Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol Apr 2000;29(2):197-207.

Merrill RM, Feuer EJ. Risk-adjusted cancer-incidence rates (United States). Cancer Causes Control Sep 1996;7(5):544-52.

Merrill RM, Feuer EJ, Warren JL, Schussler N, Stephenson RA. Role of transurethral resection of the prostate in population-based prostate cancer incidence rates. Am J Epidemiol 15 Oct 1999;150(8):848-60.

Merrill RM, Kessler LG, Udler JM, Rasband GC, Feuer EJ. Comparison of risk estimates for selected diseases and causes of death. Prev Med Feb 1999;28(2):179-93.

Merrill RM, Potosky AL, Feuer EJ. Changing trends in U.S. prostate cancer incidence rates. J Natl Cancer Inst 20 Nov 1996;88(22):1683-5.

Merrill RM, Weed DL, Feuer EJ. The lifetime risk of developing prostate cancer in white and black men. Cancer Epidemiol Biomarkers Prev Oct 1997;6(10):763-8.

Midthune DN, Fay MP, Clegg L, Feuer EJ. Modeling reporting delay and reporting corrections in cancer registry data. J Am Stat Assoc Mar 2005;100(469):61-70.

Miller BA, Feuer EJ, Hankey BF. Breast cancer. N Engl J Med 10 Dec 1992;327(24):1756-7.

Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993;43(1):27-41.

Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control Mar 1991;2(2):67-74.

Miller BA, Feuer EJ, Hankey BF. The significance of the rising incidence of breast cancer in the United States. Important Adv Oncol 1994193-207.

Miller BA, Feuer EJ, Hankey BF. Trends in invasive breast cancer incidence among American women (Stat Bite). J Natl Cancer Inst 1991;83:678.

Miller BA, Scoppa SM, Feuer EJ. Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers. Cancer 1 Feb 2006;106(3):670-82.

Mungiole M, Pickle LW, Simonson KH. Application of a weighted head-banging algorithm to mortality data maps. Stat Med 15 Dec 1999;18(23):3201-9.

Mungiole M, Pickle LW, Simonson KH. Effects of smoothing mortality data using the weighted head-banging algorithm. Proceedings of Biometrics Section, American Statistical Association Meeting; 1998; Dallas, TX. 1999. p. 43-51.

Mungiole M, Pickle LW, Simonson KH, White AA. Application of a weighted headbanging algorithm to mortality data maps. Proceedings of Statistical Graphics Section of the 1996 Annual Meeting of the American Statistical Association; 1997. p. 45-49.

Nandram B, Pickle LW. A Bayesian analysis of trends in U.S. homicide rates. Proceedings of Section on Bayesian Statistical Sciences of the 1999 Annual Meeting of the American Statistical Association; 2000. p. 66-71.

Nandram B, Sedransk J, Pickle LW. Bayesian analysis and mapping of mortality rates for chronic obstructive pulmonary disease. J Am Stat Assoc Dec 2000;95:1110-18.

Nandram B, Sedransk J, Pickle LW. Bayesian analysis of mortality rates for U.S. Health Service Areas. Sankhya B 1999;61(1):145-165.

Oliver MN, Matthews KA, Siadaty M, Hauck FR, Pickle LW. Geographic bias related to geocoding in epidemiologic studies. Int J Health Geogr 10 Nov 2005;4:29.

Oliver MN, Smith E, Siadaty M, Hauck FR, Pickle LW. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999. Am J Prev Med Feb 2006;30(2 Suppl):S67-76.

Parsons VL, Schenker N, Raghunathan TE, Xie D, Davis WW. Assessment of small area estimates from a complex survey cancer surveillance project. Proceedings of the 2006 American Statistical Association 20071645-1647.

Pickle LW. Exploring spatio-temporal patterns of mortality using mixed effects models. Stat Med Sep 2000;19(17-18):2251-63.

Pickle LW. Improving the Communication of the Geographic Patterns of Disease Through Computer-based Tools. Proceedings of American Statistical Association Statistical Graphics Section; 10 Aug 2005; Minneapolis, MN. 2006.

Pickle LW. Mapping Mortality Data in the United States. In: Elliott P, Wakefield J, Best N, Briggs D, eds. Spatial Epidemiology: Methods and Applications. New York: Oxford University Press; 2000. p. 240-252.

Pickle LW. Maximum likelihood estimation in the new computing environment. Statistical Computing and Statistical Graphics Newsletter 1991;3:6-15.

Pickle LW. Evaluating data with GIS and spatial statistical analyses. Healthy GIS 2006;Summer:1-3.

Pickle LW. Review of Graphic Discovery: a trout in the milk and other visual adventures by Howard Wainer. The American Statistician May 2006;60(2):203-203.

Pickle LW. Spatial analysis of disease. In: Beam C, ed. Biostatistical Applications in Cancer Research. Boston: Klewer Academic Publishers; Jan 2002. p. 113-150. [View PDF]

Pickle LW. Statistical graphics: invited sessions span topics, interests. Amstat News 2006;October:57-59.

Pickle LW. Usability testing of map designs. Proceedings of Symposium on the Interface of Computing Science and Statistics; 2003; Alexandria, VA. 2004. p. 42-56.

Pickle LW, Brown LM, Blot WJ. Information available from surrogate respondents in case-control interview studies. Am J Epidemiol Jul 1983;118(1):99-108.

Pickle LW, Feuer EJ, Edwards BK. Predicting cancer incidence in non-SEER counties. Proceedings of Biometrics Section of the Annual Meeting of the American Statistical Association; 2000; 2001. p. 45-52.

Pickle LW, Feuer EJ, Edwards BK. US Predicted Cancer Incidence, 1999: Complete Maps by County and State from Spatial Projection Models. NCI Cancer Surveillance Monograph Series, Number 5. Bethesda, MD: National Cancer Institute; 2003. NIH Publication No. 03-543. Available at http://srab.cancer.gov/incidence/monograph.html.

Pickle LW, Gillum RF. Geographic variation in cardiovascular disease mortality in US blacks and whites. J Natl Med Assoc Oct 1999;91(10):545-56.

Pickle LW, Hao Y, Jemal A, Zou Z, Tiwari RC, Ward E, Hachey M, Howe HL, Feuer EJ. A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin 2007;57(1):30-42.

Pickle LW, Hartman AM. Indicator foods for vitamin A assessment. Nutr Cancer 1985;7(1-2):3-23.

Pickle LW, Heineman EF, Ward MH, Nuckols JR, Gumpertz ML, Bell BS. Applications of GIS to cancer research at the National Cancer Institute. Proceedings of 2001 ESRI international health geographics conference; Washington, DC. 2001.

Pickle LW, Herrmann DJ. Cognitive research for the design of statistical rate maps. Proceedings of Survey Research Section of the 1999 Annual Meeting of the American Statistical Association; 2000. p. 185-191.

Pickle LW, Herrmann DJ. The process of reading statistical maps: The effect of color. Statistical Computing and Statistical Graphics Newsletter 1994;5(1):12-16.

Pickle LW, Herrmann DJ, Kerwin J, Croner CM, White AA. The impact of statistical graphic design on interpretation of disease rate maps. Proceedings of Statistical Graphics Section, American Statistical Association Meeting; 12 Aug 1993; San Francisco, CA. Alexandria, VA: ASA; 1994. p. 111-116.

Pickle LW, Herrmann DJ, Mungiole M, White AA. Design of the new U.S. mortality atlas. Proceedings of International Symposium on Computer Mapping in Epidemiology and Environmental Health; 14 Feb 1995; Tampa, FL. 1997. p. 4-12.

Pickle LW, Johnson KA. Estimating the long-term probability of developing breast cancer. J Natl Cancer Inst 20 Dec 1989;81(24):1854-5.

Pickle LW, Mason TJ, Howard N, Hoover R, Fraumeni JF Jr. Atlas of U.S.Cancer Mortality among Nonwhites, 1950-1980. DHHS Publ. No. (NIH) 90–1582. Washington, DC: U.S. Gov. Printing Office; 1987.

Pickle LW, Mason TJ, Howard N, Hoover R, Fraumeni JF Jr. Atlas of U.S. cancer mortality among whites, 1950-1980. DHHS Publ. No. (NIH) 87–2900. Washington, DC: U.S. Gov. Printing Office; 1990.

Pickle LW, McCormick GP. Estimation of the variance matrix for maximum likelihood parameters using quasi-Newton methods. Proceedings of 20th Symposium on the Interface of Computer Science and Statistics; 1988.

Pickle LW, Mulvihill JJ. An example of sample size determination for family studies. Am J Epidemiol Sep 1981;114(3):299-303.

Pickle LW, Mungiole M, Gillum RF. Geographic variation in stroke mortality in blacks and whites in the United States. Stroke Aug 1997;28(8):1639-47.

Pickle LW, Mungiole M, Jones GK, White AA. Analysis of mapped mortality data by mixed effects models. Proceedings of Biometrics Section, American Statistical Association Meeting; 1996; Chicago, IL. 1997. p. 227-232.

Pickle LW, Mungiole M, Jones GK, White AA. Atlas of United States Mortality. Hyattsville, Maryland: National Center for Health Statistics; 1996.

Pickle LW, Mungiole M, Jones GK, White AA. Exploring spatial patterns of mortality: the new atlas of United States mortality. Stat Med 15 Dec 1999;18(23):3211-20.

Pickle LW, Mungiole M, Jones GK, White AA. Statistical analysis and graphical design for the new U.S. mortality atlas. Proceedings of Biometrics Section, American Statistical Association Meeting; 1995; Orlando, FL. 1996. p. 573-8.

Pickle LW, Su Y. Within-state geographic patterns of health insurance coverage and health risk factors in the United States. Am J Prev Med Feb 2002;22(2):75-83. [View PDF]

Pickle LW, Waller LA, Lawson AB. Current practices in cancer spatial data analysis: a call for guidance. Int J Health Geogr 13 Jan 2005;4(1):3.

Pickle LW, White AA. Effects of the choice of age-adjustment method on maps of death rates. Stat Med Mar 1995;14(5-7):615-27.

Pickle LW, White AA, Mungiole M, Jones GK. Atlas of United States Mortality. Proceedings of Statistical Graphics Section, American Statistical Association Meeting; 1996; Chicago, IL. 1997. p. 40-44.

Potischman N, Troisi R, Thadhani R, Hoover RN, Dodd K, Davis WW, Sluss PM, Hsieh CC, Ballard-Barbash R. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev Jun 2005;14(6):1514-20.

Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 15 Sep 2004;96(18):1358-67.

Potosky AL, Feuer EJ, Levin DL. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 2001;23(1):181-6.

Potosky AL, Harlan LC, Stanford JL, Gilliland FD, Hamilton AS, Albertsen PC, Eley JW, Liff JM, Deapen D, Stephenson RA, Legler J, Ferrans CE, Talcott JA, Litwin MS. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 20 Oct 1999;91(20):1719-24.

Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst 17 Oct 1990;82(20):1624-8.

Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 4 Oct 2000;92(19):1582-92.

Potosky AL, Merrill RM, Riley GF, Taplin SH, Barlow W, Fireman BH, Ballard-Barbash R. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst 19 Nov 1997;89(22):1683-91.

Potosky AL, Merrill RM, Riley GF, Taplin SH, Barlow W, Fireman BH, Lubitz JD. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res Jun 1999;34(2):525-46.

Raghunathan TE, Xie D, Schenker N, Parsons VL, Davis WW, Dodd KW, Feuer EJ. Combining Information from two surveys to estimate county level prevalence rates of cancer risk factors and screening. J Am Stat Assoc 2007;102(478):474-86.

Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 19 Apr 2007;356(16):1670-4.

Richards TB, Pickle LW, Rushton G, Miller BA. Special issue: Prostate cancer and geographic information systems (GIS). American Journal of Preventive Medicine 2006;30(2):S1-S118.

Riley GF, Feuer EJ, Lubitz JD. Disenrollment of Medicare cancer patients from health maintenance organizations. Med Care Aug 1996;34(8):826-36.

Rimer BK, Meissner HI, Breen N, Legler JM, Coyne C. Social and behavioral interventions to increase breast cancer screening. In: Schneiderman N, Speers MA, Silva JM, Tomes H, Gentry JH, eds. Integrating Behavioral and Social Sciences with Public Health . Washington DC: APA; Oct 2000.

Roetzheim R, Fox SA, Leake B, Houn F. The influence of risk factors on breast carcinoma screening of Medicare-insured older women. National Cancer Institute Breast Cancer Screening Consortium. Cancer 15 Dec 1996;78(12):2526-34.

Rowland JH, Aziz N, Tesauro G, Feuer EJ. The changing face of cancer survivorship. Semin Oncol Nurs Nov 2001;17(4):236-40.

Sammel MD, Ryan LM, Legler JM. Latent variable models for mixed discrete and continuous outcomes. Journal of the Royal Statistical Society: Series B 1997;59(3):667-688.

Sammel MD, Ryan LM, Legler JM. Latent variable models for teratogenesis using multiple binary outcomes. J Am Stat Assoc 1997;92(437):13-20.

Schenck AP, Klabunde CN, Davis WW. Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med Apr 2006;30(4):320-6.

Schenck AP, Klabunde CN, Warren JL, Peacock S, Hawley ST, Pignone M, Ransohoff D. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev 2007;16:2118-2127.

Schenk AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff D. Evaluations of claims, medical records and self-report for measuring fecal occult blood testing among medicare enrollees in fee-for-service. Cancer Epidemiol Biomarkers Prev In Press.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care Mar 2004;42(3):239-50.

Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med Feb 2004;19(2):146-55.

Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev Mar 2003;22(1):25-38.

Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. Am J Epidemiol 1 Dec 2004;160(11):1059-69.

Shih JH. A class of permutation tests for stratified survival data. Biometrics Dec 1999;55(4):1156-61.

Simonetti A, Gigli A, Capocaccia R, Mariotto A. Estimating complete prevalence of cancers diagnosed in childhood. Stat Med 30 Mar 2008;27(7):990-1007.

Singh GK, Miller BA, Hankey BF, Feuer EJ, Pickle LW. Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part I--All cancers among men. J Natl Cancer Inst 19 Jun 2002;94(12):904-15.

Stables GJ, Subar AF, Patterson BH, Dodd K, Heimendinger J, Van Duyn MA, Nebeling L. Changes in vegetable and fruit consumption and awareness among US adults: results of the 1991 and 1997 5 A Day for Better Health Program surveys. J Am Diet Assoc Jun 2002;102(6):809-17.

Stillman F, Hartman A, Graubard B, Gilpin E, Chavis D, Garcia J, Wun LM, Lynn L, Manley M. The American Stop Smoking Intervention Study. Conceptual framework and evaluation design. Eval Rev Jun 1999;23(3):259-80.

Stillman FA, Cronin KA, Evans WD, Ulasevich A. Can media advocacy influence newspaper coverage of tobacco: measuring the effectiveness of the American stop smoking intervention study's (ASSIST) media advocacy strategies. Tob Control Jun 2001;10(2):137-44.

Stotts RC, Kessler L, Hershey JC, Hall JG, Gruman JG. Awarding Health: Contracts at the National Institutes of a Sensitivity Analysis of the Critical Parameters. Intl Transactions in Oper Res Apr 1994;1(2):117-124.

Swan J, Breen N, Burhansstipanov L, Satter DE, Davis WW, McNeel T, Snipp CM. Cancer screening and risk factor rates among American Indians. Am J Public Health Feb 2006;96(2):340-50.

Tilley BC, Marler J, Geller NL, Lu M, Legler J, Brott T, Lyden P, Grotta J. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke Nov 1996;27(11):2136-42.

Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res Dec 2006;15(6):547-69.

Tiwari RC, Cronin KA, Davis WW, Feuer EJ, Yu B, Chib S. Bayesian model selection for join point regression with application to age-adjusted cancer rates. Journal of the Royal Statistical Society, Series C, Applied Statistics Nov 2005;54 (5):919-939.

Tiwari RC, Ghosh K. Prediction of US Cancer Mortality Counts Using Semiparametric Bayesian Techniques. J Am Stat Assoc Mar 2007;102:7-15.

Tiwari RC, Ghosh K, Jemal A, Hachey M, Ward E, Thun MJ, Feuer EJ. A new method of predicting US and state-level cancer mortality counts for the current calendar year. CA Cancer J Clin 2004;54(1):30-40.

Tiwari RC, Kulasekera KB, Park C. Nonparametric tests for cause specific hazard rates with censored data for competing risks among several groups. Journal of Statistical Planning and Inference 1 May 2006;136(5):1718-1745.

Troendle JF, Legler JM. A comparison of one-sided methods to identify significant individual outcomes in a multiple outcome setting: stepwise tests or global tests with closed testing. Stat Med 15 Jun 1998;17(11):1245-60.

U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999 Incidence. Atlanta, GA: Department of Health and Human Services, Centers for Disease and Prevention and National Cancer Institute; 2002. Available at http://www.cdc.gov/cancer/npcr/uscs/pdf/1999_USCS.pdf.

Van Duyn MA, Kristal AR, Dodd K, Campbell MK, Subar AF, Stables G, Nebeling L, Glanz K. Association of awareness, intrapersonal and interpersonal factors, and stage of dietary change with fruit and vegetable consumption: a national survey. Am J Health Promot 2001;16(2):69-78.

Vener KJ, Feuer EJ, Gorelic L. A statistical model validating triage for the peer review process: keeping the competitive applications in the review pipeline. FASEB J Nov 1993;7(14):1312-9.

Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer Jul 2003;39(11):1603-9.

Wang X, Chen JX, Carr DB, Bell BS, Pickle LW. Geographic statistics visualization: Web-based linked micromap plots. Computing in Science & Engineering Jun 2002;4(3):90-94.

Warren JL, Brown ML, Fay MP, Schussler N, Potosky AL, Riley GF. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol 1 Jan 2002;20(1):307-16.

Warren JL, Feuer E, Potosky AL, Riley GF, Lynch CF. Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care May 1999;37(5):445-56.

Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 1 Nov 2005;104(9):1840-8.

Weller EA, Feuer EJ, Frey CM, Wesley MN. Parametric relative survival modelling using generalized linear models with application to Hodgkin Lymphoma. Applied Statistics: Journal of the Royal Statistical Society -Series C 1999;48(1):79-89.

White AA, Pickle LW, Herrmann DJ, Croner CM, Wilson BF. Map design preferences associated with professional discipline. Proceedings of Statistical Graphics Section, American Statistical Association Meeting; 1994; Toronto, Canada. 2005. p. 54-59.

Wideroff L, Freedman AN, Olson L, Klabunde CN, Davis W, Srinath KP, Croyle RT, Ballard-Barbash R. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev Apr 2003;12(4):295-303.

Woodward RM, Brown ML, Stewart ST, Cronin KA, Cutler DM. The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF. Cancer 1 Dec 2007;110(11):2511-8.

Wun L. Regression analysis of autocorrelated poisson-distributed data. Communications in Statistics: Theory and Methods 1991;20(10):3083-3091.

Wun L, Brown CC. An alternative decision rule for quality control in sequential sampling plans. Communications in Statistics:Theory and Methods 1993;22(7):2033-42.

Wun L, Pearl WL. Accessing the statistical characteristics of the mean absolute error of forecasting. Intl J Forecasting Nov 1991;7(3):335-337.

Wun LM, Feuer EJ, Miller BA. Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control Mar 1995;6(2):135-44.

Wun LM, Merrill RM, Feuer EJ. Estimating lifetime and age-conditional probabilities of developing cancer. Lifetime Data Anal 1998;4(2):169-86.

Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL. Patient time costs associated with cancer care. J Natl Cancer Inst 3 Jan 2007;99(1):14-23.

Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 1 Sep 2004;96(17):1322-30.

Yabroff KR, Mariotto AB, Feuer EJ, Brown M. Projections of the Costs Associated with Colorectal Cancer Care in the United States, 2000 to 2020. J Health Econ 2007.

Yabroff KR, Warren JL, Knopf K, Davis WW, Brown ML. Estimating patient time costs associated with colorectal cancer care. Med Care Jul 2005;43(7):640-8.

Yabroff R, McNeel T, Waldron WR, Davis WW, Brown ML, Clauser S, Lawrence W. Health limitations and quality of life associated with cancer and other chronic diseases by phase of care. Medical Care 2007;45(7):629-637.

Yoder C, Weitzen S, Pickle LW, Grant B, Herrmann DJ, Schnitzer S. Cognitive functioning in the last year of life as a function of age, gender, and race. Experimental Aging Research 1 Jul 2001;27:241-256.

Yu B. Estimation of shared Gamma frailty models by a modified EM algorithm. Computational Statistics and Data Analysis 30 Jan 2006;50:436-74.

Yu B, Barrett MJ, Kim H, Feuer EJ. Estimating joinpoints in continuous time scale for multiple change-point models. Computational Statistics and Data Analysis 1 Feb 2007;51(5):2420-7.

Yu B, Tiwari RC. Application of EM algorithm to mixture cure model for grouped relative survival data. Journal of Data Science Jan 2007;5(1):41-51.

Yu B, Tiwari RC. Multiple imputation methods for modelling relative survival data. Stat Med 15 Sep 2006;25(17):2946-55.

Yu B, Tiwari RC, Cronin KA, Feuer EJ. Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med 15 Jun 2004;23(11):1733-47.

Yu B, Tiwari RC, Cronin KA, McDonald C, Feuer EJ. CANSURV: A Windows program for population-based cancer survival analysis. Comput Methods Programs Biomed Dec 2005;80(3):195-203.


Last modified:
05 Mar 2008
Search | Contact Us | Accessibility | Privacy Policy
DCCPS National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal